Drug executives should take a Hippocratic oath

Bob More ()

Nature, 2018, vol. 555, issue 7698, 561-561

Abstract: The industry must earn patients’ trust that new medicines really are worth the price, says Bob More.

Keywords: Drug discovery; Biotechnology; Ethics; Industry (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-018-03230-4 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:555:y:2018:i:7698:d:10.1038_d41586-018-03230-4

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-018-03230-4

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().